TLR2 and glioma: In murine GL261 glioma cells implanted in TLR2 knockout mice, the lack of TLR2 resulted in significantly smaller tumors, reduced membrane type 1 matrix metalloprotease (MT1-MMP) expression, and enhanced survival rates compared with wild-type control mice.